Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qili Qiangxin Capsules for chronic heart failure
ChiCTR-TRC-11001478Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qiliqiangxin in chronic heart failure (CHF) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: NT-proBNP and Composite event. Started Jun 2011; status: completed.
02
Drugs
qiliqiangxin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-TRC-11001478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001478.